Skip to main content
Smart Investors Daily
InnovAge Holding Corp. logo

NASDAQ · INNV

InnovAge Holding Corp.

Healthcare · Medical - Care Facilities

$10.94

Down-$0.16 (-1.44%)

Updated Aug 20, 2026, 5:51 AM

SID Score

6.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
724.13M
P/E ratio
-41.77
Dividend yield
0.00%
52-week range
$3.26 – $12.64
Volume
158.04K
Avg. volume
130.78K

Price performance

INNV price history

1M range · 0 trading sessions · Daily adjusted prices

INNV does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest INNV news

The latest Smart Investors Daily articles mentioning INNV.

INNV research

Overview

Company profile and research snapshot.

Company profile

InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$6.80
Implied upside
Analysts
INNV recent ratings
DateFirmRatingTarget
Feb 23, 2026JP MorganUnderweight
Dec 17, 2024JP MorganUnderweight
Oct 11, 2024KeybancSector Weight
Mar 13, 2024JP MorganNeutral
Feb 8, 2024Goldman SachsNeutral
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.